There has been a story in March 2023 about a USC professor accused of plagiarism (direct quote paragraphs) in a new book. Here.
Can GPT4 be a "de-plagiarizer?"
####
I need to utilize the following information, and there are only so many ways to write it. It is a few basic facts. Please rewrite enough so that it is not plagiarism, but recapituate the same several simple facts.
ORIGINAL TEXT FROM WIKIPEDIA
/ On 1 November 2018, Illumina, Inc. agreed to purchase PacBio for US$1.2 billion in cash. The deal was expected to close in the fourth quarter of 2019.[13] In December 2019, the Federal Trade Commission sued to block the acquisition.[14][15] The deal was abandoned with an announcement on 2 January 2020. Illumina further agreed to pay Pacific Biosciences a $98 million US termination fee plus previously agreed upon deal extension payments of $22 million US in February and $6 million US in March 2020
RE WRITE 1
On November 1, 2018, Illumina, Inc. entered into an agreement to acquire PacBio for a sum of $1.2 billion in cash. The transaction was anticipated to be finalized in the last quarter of 2019. However, in December 2019, the Federal Trade Commission took legal action to prevent the acquisition from taking place. Consequently, the deal was officially terminated on January 2, 2020. As a result of the cancellation, Illumina consented to pay Pacific Biosciences a termination fee of $98 million, in addition to the previously agreed upon extension payments of $22 million in February and $6 million in March 2020.
RE WRITE 2
Could you rewrite it again, keeping the same basic facts but making it sound more different.
Illumina, Inc. reached a consensus to acquire PacBio at a price of $1.2 billion in cash on the 1st of November, 2018. The completion of the acquisition was slated for the fourth quarter of 2019. However, the Federal Trade Commission initiated a lawsuit in December 2019 to halt the merger. Subsequently, on January 2, 2020, the parties announced the dissolution of the deal. As a consequence, Illumina committed to compensate Pacific Biosciences with a $98 million termination fee and additional prearranged extension payments amounting to $22 million in February and $6 million in March 2020.